Scientists from Emory University School of Medicine and the University of Pavia, Italy, have determined for the first time the three-dimensional structure of monoamine oxidase B (MAO B) — an enzyme ...

Monoamine oxidase inhibitors (MAOIs) have a long and prosperous history as medications for major depressive disorder (MDD). But this type of antidepressant has mostly seen its day. Though MAOIs are ...

Maynard and Schenker 1 have reported that monoamine oxidase from mouse liver is inhibited by ethanol in vitro; however, these authors could not obtain similar inhibition of monoamine oxidase of mouse ...

Preoperative oral antibiotic bowel preparation regimens in radical cystectomies with continent diversion. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, and safety of rasagiline are reviewed. Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and selectively ...

Although recent studies demonstrate that tobacco cigarette smoke substantially inhibits both central nervous system and blood platelet monoamine oxidase (MAO) activity, little is known about the time ...

Previous research has suggested that the severe acute respiratory syndrome 2 (SARS-CoV-2) virus affects the brain and causes enduring neurological problems. However, how the virus causes various ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Alternatives with new mechanisms of action are needed after 50 years of drug development focusing on ...

Researchers at North China Electric Power University and collaborators have developed novel radiolabels for the membrane-bound monoamine oxidase-B that feature a coumarin core.

The French Society for Biological Psychiatry and Neuropsychopharmacology has unveiled revised guidelines for the management of depressive disorders with partial and resistant responses to treatment.

Oligopelvis-GETUG P07: A multicenter phase II trial of combined salvage radiotherapy and hormone therapy in oligorecurrent pelvic node relapses of prostate cancer. Randomized phase II study of ...